JP4643754B1 - Hair restorer - Google Patents
Hair restorer Download PDFInfo
- Publication number
- JP4643754B1 JP4643754B1 JP2010152080A JP2010152080A JP4643754B1 JP 4643754 B1 JP4643754 B1 JP 4643754B1 JP 2010152080 A JP2010152080 A JP 2010152080A JP 2010152080 A JP2010152080 A JP 2010152080A JP 4643754 B1 JP4643754 B1 JP 4643754B1
- Authority
- JP
- Japan
- Prior art keywords
- hair
- growth
- ovarian membrane
- salmon
- period
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000012528 membrane Substances 0.000 claims abstract description 24
- 230000002611 ovarian Effects 0.000 claims abstract description 22
- 241000972773 Aulopiformes Species 0.000 claims abstract description 14
- 108091005804 Peptidases Proteins 0.000 claims abstract description 12
- 102000035195 Peptidases Human genes 0.000 claims abstract description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 6
- 230000000593 degrading effect Effects 0.000 claims description 2
- 239000000463 material Substances 0.000 claims 1
- 230000003779 hair growth Effects 0.000 abstract description 18
- 241000699666 Mus <mouse, genus> Species 0.000 description 14
- 201000004384 Alopecia Diseases 0.000 description 13
- 239000003795 chemical substances by application Substances 0.000 description 11
- 230000012010 growth Effects 0.000 description 10
- 208000024963 hair loss Diseases 0.000 description 10
- 230000003676 hair loss Effects 0.000 description 10
- 230000008859 change Effects 0.000 description 7
- 239000000706 filtrate Substances 0.000 description 7
- 241000251468 Actinopterygii Species 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 230000009471 action Effects 0.000 description 6
- 235000019688 fish Nutrition 0.000 description 6
- 239000003163 gonadal steroid hormone Substances 0.000 description 6
- 239000000203 mixture Substances 0.000 description 5
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 4
- 239000007864 aqueous solution Substances 0.000 description 4
- 230000000052 comparative effect Effects 0.000 description 4
- 235000013601 eggs Nutrition 0.000 description 4
- 241000699670 Mus sp. Species 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 210000001672 ovary Anatomy 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 235000019515 salmon Nutrition 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 241000252203 Clupea harengus Species 0.000 description 2
- 241000723298 Dicentrarchus labrax Species 0.000 description 2
- 241000276457 Gadidae Species 0.000 description 2
- 108090000723 Insulin-Like Growth Factor I Proteins 0.000 description 2
- 102000004218 Insulin-Like Growth Factor I Human genes 0.000 description 2
- 239000004365 Protease Substances 0.000 description 2
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 2
- 230000001133 acceleration Effects 0.000 description 2
- 206010000496 acne Diseases 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 231100000360 alopecia Toxicity 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000003698 anagen phase Effects 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 230000003778 catagen phase Effects 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 230000031774 hair cycle Effects 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 235000019514 herring Nutrition 0.000 description 2
- 230000000051 modifying effect Effects 0.000 description 2
- 235000019362 perlite Nutrition 0.000 description 2
- 239000010451 perlite Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- UPXRTVAIJMUAQR-UHFFFAOYSA-N 4-(9h-fluoren-9-ylmethoxycarbonylamino)-1-[(2-methylpropan-2-yl)oxycarbonyl]pyrrolidine-2-carboxylic acid Chemical compound C1C(C(O)=O)N(C(=O)OC(C)(C)C)CC1NC(=O)OCC1C2=CC=CC=C2C2=CC=CC=C21 UPXRTVAIJMUAQR-UHFFFAOYSA-N 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 241000277269 Oncorhynchus masou Species 0.000 description 1
- 241000277275 Oncorhynchus mykiss Species 0.000 description 1
- 241000277277 Oncorhynchus nerka Species 0.000 description 1
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- 238000000692 Student's t-test Methods 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 208000004631 alopecia areata Diseases 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 230000009849 deactivation Effects 0.000 description 1
- 238000004042 decolorization Methods 0.000 description 1
- 238000005238 degreasing Methods 0.000 description 1
- 238000004332 deodorization Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 210000003278 egg shell Anatomy 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000005555 hypertensive agent Substances 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 229960004184 ketamine hydrochloride Drugs 0.000 description 1
- YECIFGHRMFEPJK-UHFFFAOYSA-N lidocaine hydrochloride monohydrate Chemical compound O.[Cl-].CC[NH+](CC)CC(=O)NC1=C(C)C=CC=C1C YECIFGHRMFEPJK-UHFFFAOYSA-N 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- -1 pack Substances 0.000 description 1
- 238000011085 pressure filtration Methods 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 210000004761 scalp Anatomy 0.000 description 1
- 210000002374 sebum Anatomy 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000002453 shampoo Substances 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000012353 t test Methods 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
- 235000020138 yakult Nutrition 0.000 description 1
Landscapes
- Cosmetics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
【課題】 サケ属の魚類の卵巣膜から抽出された抽出物の新たな用途を提供する。
【解決手段】本発明は、サケ属の魚類の卵巣膜をタンパク分解酵素で処理することにより抽出された抽出物を、経皮投与剤として育毛剤に用いる。
【選択図】 図1PROBLEM TO BE SOLVED: To provide a new use of an extract extracted from an ovarian membrane of a salmon fish.
In the present invention, an extract extracted by treating a ovarian membrane of a salmon fish with a proteolytic enzyme is used as a hair growth agent as a transdermal administration agent.
[Selection] Figure 1
Description
本発明は、サケ属の魚類の卵巣膜から抽出された抽出物を含む育毛剤に関する。 The present invention relates to a hair restorer comprising an extract extracted from the ovarian membrane of salmon fish.
従来、魚類の卵巣膜(魚卵外皮)を予めオゾン水で処理した後、その構成タンパク質である筋原線維タンパク質を酵素分解してアミノ酸及びペプチドを抽出する方法が知られている(例えば、特許文献1参照)。 Conventionally, a method is known in which fish ovary membrane (egg egg skin) is treated with ozone water in advance, and then myofibrillar protein, which is a constituent protein, is enzymatically decomposed to extract amino acids and peptides (for example, patents). Reference 1).
前記アミノ酸及びペプチドは、生理活性物質として、あるいは食品強化剤として用いることができるとされており、さらに詳しくは、ACE阻害活性を備え、血圧上昇抑制剤(降圧剤)として作用するとされている。 It is said that the amino acids and peptides can be used as physiologically active substances or as food fortifiers, and more specifically, have ACE inhibitory activity and act as blood pressure increase inhibitors (hypertensive agents).
また、マダラ科、タラ科、ニシン科の魚類の卵巣膜をタンパク分解酵素であるプロテアーゼで処理して得られた抽出物を化粧品製剤として用いることが知られている(例えば、特許文献2参照)。 In addition, it is known that an extract obtained by treating the ovarian membrane of a fish of the cod family, cod family, and herring family with a protease that is a proteolytic enzyme is used as a cosmetic preparation (see, for example, Patent Document 2). .
前記マダラ科、タラ科、ニシン科の魚類の卵巣膜をプロテアーゼで処理して得られた抽出物は、性ホルモンの作用の活性化及び抑制を行い、性ホルモンのバランスを正常化する作用(性ホルモン修飾作用)を有するとされている。そして、前記化粧品製剤は、前記抽出物の性ホルモン修飾作用により、皮脂の分泌を抑制し、ニキビ、吹き出物、肌荒れ、シワ等の改善に効果があるとされている。 The extract obtained by treating the ovarian membrane of the codfish family, codfish family, and herring family with a protease activates and suppresses the action of sex hormones and normalizes the balance of sex hormones (sex Hormone modifying action). The cosmetic preparation is said to be effective in improving acne, pimples, rough skin, wrinkles and the like by suppressing the secretion of sebum by the sex hormone modifying action of the extract.
さらに、鮭の卵巣膜をタンパク分解酵素で処理することにより抽出された抽出物を加速度脈波加齢指数上昇剤、IGF−1値上昇剤、肌荒れ改良材として用いることが知られている(特許文献3〜5参照)。 Furthermore, it is known to use an extract extracted by treating the ovarian membrane of salmon with a proteolytic enzyme as an acceleration pulse wave aging index increasing agent, an IGF-1 level increasing agent, and a rough skin improving agent (patent) Reference 3-5).
しかしながら、魚類の卵巣膜から抽出された抽出物には、前記血圧の高圧作用、性ホルモン修飾作用、加速度脈波加齢指数上昇作用、IGF−1値上昇作用、肌荒れ改良作用以外の作用は知られておらず、さらに多くの用途の開発が望まれる。 However, the extract extracted from the ovarian membrane of fish has no effects other than the high-pressure action of blood pressure, the sex hormone modification action, the acceleration pulse wave aging index raising action, the IGF-1 value raising action, and the rough skin improving action. Development of many more applications is desired.
本発明は、かかる事情に鑑み、サケ属の魚類の卵巣膜から抽出された抽出物の新たな用途を提供することを目的とする。 In view of such circumstances, an object of the present invention is to provide a new use of an extract extracted from the ovarian membrane of salmon fish.
かかる目的を達成するため、本発明剤は、サケ属の魚類の卵巣膜をタンパク質分解酵素で分解することにより、水中に溶出された成分を経皮投与材として育毛剤に用いることを特徴とする。 In order to achieve such an object, the agent of the present invention is characterized by using a component eluted in water as a transdermal administration agent for a hair growth agent by degrading the ovarian membrane of salmon fish with a proteolytic enzyme. .
毛髪は、一定の周期で発毛と脱毛を繰り返している。これを毛周期と呼び、大きく分けて、成長期、退行期、休止期の3段階に分類される。成長期は、毛母細胞が分裂を繰り返し、毛髪が成長する期間である。退行期は、成長を終えた毛髪の毛根が頭皮表面に移動する期間であり、休止期は寿命を終えた毛髪が抜け落ちると共に、毛包に新しい毛母細胞が発生し、再び成長期となるまでの期間である。 The hair repeats hair growth and hair loss at regular intervals. This is called a hair cycle, and is roughly classified into three stages: a growth period, a regression period, and a rest period. Growth period is a period in which hair matrix cells repeat division and hair grows. The regression phase is the period during which the root of the hair that has finished growing moves to the scalp surface. Is the period.
生体においては、男性型脱毛症、脂漏性脱毛症、ひこう性脱毛症、円形脱毛症等が発生し、毛髪量が減少することがある。このような毛髪量の減少は、例えば、性ホルモン、ストレス、遺伝、食事・生活習慣等に起因するものであるが、結果としては前記成長期が短くなることによる。 In a living body, male pattern alopecia, seborrheic alopecia, scoliotic alopecia, alopecia areata and the like may occur, and the amount of hair may decrease. Such a reduction in the amount of hair is caused by, for example, sex hormones, stress, inheritance, diet / lifestyle, and the like, but as a result, the growth period is shortened.
ところが、本発明の育毛剤によれば、成長期の期間を延長させることができるため、脱毛に伴う毛髪量の減少を緩和、改善し、成長期の健康な毛髪量を増加させるという育毛効果を得ることができる。 However, according to the hair restorer of the present invention, since the period of the growth period can be extended, the hair growth effect of alleviating and improving the decrease in the amount of hair associated with hair loss and increasing the amount of healthy hair during the growth period. Obtainable.
尚、本願において、「育毛」という用語は、「発毛」、「養毛」等の用語の概念を含む。 In the present application, the term “hair growth” includes the concept of terms such as “hair growth” and “hair growth”.
本実施形態の育毛剤は、サケ属の魚類の卵巣膜をタンパク分解酵素で処理することにより抽出された抽出物(以下、卵巣膜抽出物と略記する)を含む経皮投与剤である。 The hair growth agent of this embodiment is a transdermal administration agent containing an extract (hereinafter abbreviated as ovarian membrane extract) extracted by treating the ovarian membrane of salmon fish with a proteolytic enzyme.
前記サケ属の魚類としては、白ザケ、紅ザケ、銀ザケ、ニジマス、サクラマス、マスノスケ等を挙げることができる。前記サケ属の魚類の卵巣膜は、該サケ属の魚類の魚卵外皮であり、卵巣から魚卵を採取した後の外皮のみを水洗することにより得ることができる。 Examples of the salmon fish include white salmon, red salmon, silver salmon, rainbow trout, cherry salmon, and salmon. The ovarian membrane of the salmon fish is the fish egg shell of the salmon fish, and can be obtained by washing only the shell after the fish egg is collected from the ovary.
前記卵巣膜抽出物は、例えば、魚卵から分離された前記卵巣膜を酵素処理することにより分解されたタンパク質が溶出した溶液をメタノール沈殿させ、得られる沈殿物をろ過して回収する方法等により得ることができる。 The ovarian membrane extract is obtained by, for example, a method in which a solution from which protein decomposed by enzymatic treatment of the ovarian membrane separated from fish eggs is precipitated with methanol, and the resulting precipitate is collected by filtration. Obtainable.
前記方法では、具体的には、まず、サケ属の魚類、例えば、北海道産白ザケの卵巣膜を原料とし、該卵巣膜に対して水を加えて撹拌、混合する。次に、タンパク分解酵素としてタンパク質分解酵素アロアーゼNS(ヤクルト薬品工業株式会社製)を添加し、6.5〜7の範囲にpHに維持し、43〜52℃の範囲の温度で2時間、攪拌しながら反応させる。この結果、前記卵巣膜に含有される成分のうち、前記タンパク分解酵素で分解された成分が水中に溶出し、該成分の水溶液が得られる。 Specifically, in the method, first, salmon fish, for example, Hokkaido ovary membrane of white salmon is used as a raw material, water is added to the ovarian membrane, and the mixture is stirred and mixed. Next, proteolytic enzyme alloase NS (manufactured by Yakult Pharmaceutical Co., Ltd.) is added as a proteolytic enzyme, maintained at pH in the range of 6.5-7, and stirred for 2 hours at a temperature in the range of 43-52 ° C. While reacting. As a result, among the components contained in the ovarian membrane, the components decomposed by the proteolytic enzyme are eluted in water, and an aqueous solution of the components is obtained.
次に、前記水溶液に含まれている前記タンパク分解酵素を失活する。前記失活は、例えば、前記水溶液を85℃以上の温度で10分間以上加熱することにより行うことができる。 Next, the proteolytic enzyme contained in the aqueous solution is inactivated. The deactivation can be performed, for example, by heating the aqueous solution at a temperature of 85 ° C. or higher for 10 minutes or more.
次に、前記水溶液に活性炭を添加して、該ろ液の脱臭、脱色、脱脂を行う。前記ろ液の脱臭、脱色、脱脂は、該ろ液に活性炭を添加し、例えば60℃の温度で30分間加熱することにより行うことができる。 Next, activated carbon is added to the aqueous solution to deodorize, decolorize, and degrease the filtrate. Deodorization, decolorization, and degreasing of the filtrate can be performed by adding activated carbon to the filtrate and heating it at a temperature of 60 ° C. for 30 minutes, for example.
次に、前記ろ液に、ろ過助剤としてのパーライト(東興パーライト工業株式会社製)を添加し、フィルタープレスによりろ過し、得られたろ液を減圧下、例えば60℃の温度で約1/5の量になるまで濃縮した。その後、濃縮されたろ液に、体積比4倍量の99.8%以上の濃度のメタノールを添加し、沈殿物を加圧ろ過して回収する。 Next, perlite (manufactured by Toko Perlite Kogyo Co., Ltd.) as a filter aid is added to the filtrate, and the filtrate is filtered by a filter press. The obtained filtrate is reduced to about 1/5 at a temperature of 60 ° C., for example. Concentrate to Thereafter, methanol having a concentration of 99.8% or more of the four times volume ratio is added to the concentrated filtrate, and the precipitate is collected by pressure filtration.
次に、得られた前記沈殿物に、原料1kgに対して最終体積が1Lとなるように精製水を添加し、卵巣膜抽出エキスを得ることができる。 Next, purified water is added to the obtained precipitate so that the final volume becomes 1 L with respect to 1 kg of the raw material, and an ovarian membrane extract can be obtained.
前記卵巣膜抽出エキスは、有効成分を窒素換算で0.04質量%以上を含んでいる。 The ovarian membrane extract contains 0.04% by mass or more of an active ingredient in terms of nitrogen.
本発明の育毛剤は、経皮投与剤として、例えば、クリーム、乳液、ローション、ヘアトニック、スプレー、パック、溶液剤、軟膏、乳剤、懸濁剤のような塗布剤等として用いることができる。また、本発明の育毛剤は、シャンプー、コンディショナー又はトリートメント等に配合して用いることができる。 The hair growth agent of the present invention can be used as a transdermal administration agent, for example, as a coating agent such as cream, emulsion, lotion, hair tonic, spray, pack, solution, ointment, emulsion, suspension. Moreover, the hair restorer of this invention can be mix | blended and used for a shampoo, a conditioner, or a treatment.
次に、本発明の実施例と比較例とを示す。 Next, examples of the present invention and comparative examples will be described.
本実施例では、実験動物として、日本エスエルシー株式会社より購入したC57BL/6マウス(雌性、6〜7週齢)を用意し、7日間の順化飼育の後、実験を開始した。 In this example, C57BL / 6 mice (female, 6-7 weeks old) purchased from Japan SLC Co., Ltd. were prepared as experimental animals, and the experiment was started after acclimatization for 7 days.
本実験においては、塩酸ケタミンと塩酸キシロカインとをそれぞれ前記マウスの体重1kgに対して10mgの量となるように調製した混合麻酔を該マウスの背中に筋肉注射した。その後、松脂とワックスとを重量比で1:1に混合した混合物を加熱して溶解させた後、前記マウスの背中に塗布した。前記混合物が凝固したら、当該混合物を取り除くことにより、前記マウスの背中を脱毛した。 In this experiment, mixed anesthesia prepared with ketamine hydrochloride and xylocaine hydrochloride so as to be 10 mg / kg body weight of each mouse was intramuscularly injected into the back of the mouse. Thereafter, a mixture of pine resin and wax in a weight ratio of 1: 1 was heated and dissolved, and then applied to the back of the mouse. When the mixture solidified, the back of the mouse was depilated by removing the mixture.
前記マウスにおいては、毛髪の成長段階によって皮膚の色が変化し、成長期では黒色、退行期では灰色、休止期では赤色を示す。従って、前記マウスの皮膚の色を観察することにより、毛髪がどの時期であるのかを確認することができる。 In the mouse, the color of the skin changes depending on the growth stage of the hair, black in the growth period, gray in the regression period, and red in the rest period. Therefore, by observing the color of the mouse skin, it is possible to confirm when the hair is.
本実施例では、上述したように、前記マウスの背中を脱毛することにより、毛周期を成長期に誘導することができる。 In this example, as described above, the hair cycle can be induced in the growth period by removing the hair of the mouse.
次に、前記マウスの脱毛領域に、1日2回、経皮投与剤として前記卵巣膜抽出エキスを0.2ml塗布し、脱毛後25日目まで飼育を行った。そして、脱毛後の皮膚の色が黒色に変化するまでにかかる日数と、黒色に変化してから発毛までにかかる日数と、黒色に変化してから灰色に変化するまでにかかる日数とを記録した。結果を表1に示す。 Next, 0.2 ml of the ovarian membrane extract was applied as a transdermal agent twice a day to the hair loss region of the mouse, and was reared until 25 days after hair removal. Then, record the number of days it takes for the skin color after hair removal to change to black, the number of days it takes for it to change to black, and the number of days it takes for it to change to black after turning black. did. The results are shown in Table 1.
前記マウスの脱毛領域の皮膚の色が、黒色に変化したことは毛髪が成長期に進んだことを意味し、黒色から灰色に変化したことは毛髪が成長期から退行期に進んだことを意味する。 When the skin color of the mouse hair loss area changed to black, it means that the hair has progressed to the growth phase, and from black to gray means that the hair has progressed from the growth phase to the regression phase. To do.
また、本実施例のマウスについて、脱毛後、0日目、3日目、15日目、25日目における脱毛領域の写真を撮影した。結果を図1に示す。 Moreover, about the mouse | mouth of a present Example, after the hair removal, the photograph of the hair loss area | region in the 0th day, the 3rd day, the 15th day, and the 25th day was image | photographed. The results are shown in FIG.
[比較例]
本実施例では、実施例と全く同一にして、背中に脱毛領域を有するマウスを作成した。その後、前記脱毛領域を無処置の状態で、脱毛後25日目まで飼育を行った。そして、脱毛後の皮膚の色が黒色に変化するまでにかかる日数と、黒色に変化してから発毛までにかかる日数と、黒色に変化してから灰色に変化するまでにかかる日数とを記録した。結果を表1に示す。
[Comparative example]
In this example, a mouse having a hair loss region on the back was prepared in exactly the same manner as in the example. Thereafter, the hair loss region was kept untreated until the 25th day after hair removal. Then, record the number of days it takes for the skin color after hair removal to change to black, the number of days it takes for it to change to black, and the number of days it takes for it to change to black after turning black. did. The results are shown in Table 1.
また、本実施例のマウスについて、脱毛後、0日目、3日目、15日目、25日目におけるマウスの背中の写真を撮影した。結果を図1に示す。
各実施例と比較例との間でt検定を行い、p<0.05である場合に、統計学的に有意差があると判断した。
Moreover, about the mouse | mouth of a present Example, after the hair removal, the photograph of the mouse | mouth back in the 0th day, the 3rd day, the 15th day, and the 25th day was image | photographed. The results are shown in FIG.
A t-test was performed between each example and the comparative example, and when p <0.05, it was determined that there was a statistically significant difference.
図1及び表1によれば、実施例1の鮭卵巣膜抽出物を経皮投与されたマウスは、比較例1の脱毛後無処置のマウスに比較して、成長期の期間が統計学的に非常に有意に長くなっていることが明らかである(p<0.01)。 According to FIG. 1 and Table 1, the mice that were transdermally administered with the vaginal ovarian membrane extract of Example 1 had a statistically longer growth period compared to the untreated mice after hair loss of Comparative Example 1. It is clear that it is very significantly longer (p <0.01).
ここで、「育毛」、「発毛」、「養毛」という用語は、一般に明確に区別する定義はないが、本願においては、いずれも毛髪の成長期の期間を延長させることにより、健康な毛髪量を増加させることを意味する。 Here, the terms “hair growth”, “hair growth”, and “hair growth” are generally not clearly defined, but in this application, the term “hair growth”, “hair growth”, and “hair growth” It means to increase the amount of hair.
鮭卵巣膜抽出物を含有する育毛剤によれば、上述したように毛髪の成長期の期間を長くすることができるため、脱毛に伴う毛髪量の減少を緩和、改善し、成長期の健康な毛髪量を増加させるという育毛・発毛・養毛効果を得ることができることが明らかである。 According to the hair restorer containing 含有 ovarian membrane extract, as described above, the period of the hair growth period can be lengthened, so the reduction in the amount of hair associated with hair loss is alleviated and improved, and the growth period is healthy. It is clear that the effect of hair growth, hair growth, and hair nourishment that increases the amount of hair can be obtained.
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2010152080A JP4643754B1 (en) | 2010-07-02 | 2010-07-02 | Hair restorer |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2010152080A JP4643754B1 (en) | 2010-07-02 | 2010-07-02 | Hair restorer |
Publications (2)
Publication Number | Publication Date |
---|---|
JP4643754B1 true JP4643754B1 (en) | 2011-03-02 |
JP2012012354A JP2012012354A (en) | 2012-01-19 |
Family
ID=43836030
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2010152080A Active JP4643754B1 (en) | 2010-07-02 | 2010-07-02 | Hair restorer |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP4643754B1 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2014361780B2 (en) * | 2013-12-13 | 2016-11-24 | Restorsea, Llc | Exfoliative hair retention-promoting formulation |
JP6189803B2 (en) * | 2014-07-30 | 2017-08-30 | 株式会社イムダイン | Orally administered hair growth and scalp improving agents |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3946238B1 (en) * | 2006-07-03 | 2007-07-18 | 株式会社日本バリアフリー | IGF-1 level increasing agent |
-
2010
- 2010-07-02 JP JP2010152080A patent/JP4643754B1/en active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3946238B1 (en) * | 2006-07-03 | 2007-07-18 | 株式会社日本バリアフリー | IGF-1 level increasing agent |
Also Published As
Publication number | Publication date |
---|---|
JP2012012354A (en) | 2012-01-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105671018A (en) | Eggshell membrane solubilization method using enzymes | |
FR3055543A1 (en) | HAIR DYE COMPOSITION FOR MINIMIZING HAIR DAMAGE AND SCALP IRRITATION CAUSED BY AMMONIA-BASED FORMULATION AND AMMONIA ODOR, AND PROCESS FOR PRODUCING THE SAME | |
JP2011068649A (en) | Pharmaceutical composition comprising 3,4-propinoperhydropurine and use thereof for blocking neuronal transmission | |
KR101161634B1 (en) | Method for producing antler ferment solution with enhanced specific free amino acids content and antler ferment solution produced by the same method | |
JP4643754B1 (en) | Hair restorer | |
KR101711134B1 (en) | Method For Manufacturing Hair Tonic | |
JP3946238B1 (en) | IGF-1 level increasing agent | |
KR101744796B1 (en) | Permanent composition containing pumpkin fermentative products and manufacturing method the same | |
JP4599518B2 (en) | Hair care preparations | |
WO2008009655B1 (en) | Medical use of n-phenylpropenoyl-amino acid derivatives and related compounds | |
JPS6391315A (en) | Trichogenic promoter | |
EP0136352B1 (en) | Cosmetic composition and method for obtaining it | |
JP2005002041A (en) | Water-soluble pearl powder | |
CN1814282A (en) | Biological collagen oral liquor and preparing method | |
RU2448682C2 (en) | Method of treating alopecia | |
CN105106932B (en) | A kind of hair growth composition and preparation method thereof | |
US20120014898A1 (en) | Composition for preventing hair loss and stimulating hair growth | |
JP2008037770A (en) | Anti-aging agent | |
KR101611134B1 (en) | Method for preparing of cosmetic composition for regenerating skin | |
JP4005113B1 (en) | Cosmetics | |
JP4792588B2 (en) | Pore darkening agent | |
KR0178115B1 (en) | Preparation to promote hair growth | |
FR2666228A1 (en) | Composition for the treatment of excessive weight and/or of cellulite | |
KR102155435B1 (en) | Manufacturing method of a treating component for wrinkle-care and lipolysis | |
RU2324489C2 (en) | Bioactive complex "arctic+" and method of treatment of oncology diseases |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20101124 |
|
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20101202 |
|
R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 Ref document number: 4643754 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20131210 Year of fee payment: 3 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |